Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation.
Looking for a particular Qualigen Inc. employee's phone or email?
The Qualigen Inc. annual revenue was $6 million in 2026.
Paul Rosina is the President and CEO of Qualigen Inc..
14 people are employed at Qualigen Inc..
Qualigen Inc. is based in Carlsbad, California.
The NAICS codes for Qualigen Inc. are [54, 541714, 5417, 54171, 541].
The SIC codes for Qualigen Inc. are [87, 873].